These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3486754

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections.
    Mehta AP, Phutane L, Patel MH, Rupwate RU, Kamat SR.
    J Assoc Physicians India; 1991 Mar; 39(3):251-3. PubMed ID: 1880092
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
    Schaad UB, Casey PA, Cooper DL.
    Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V, Horcicková M, Hatala M, Liska M, Matousovic K.
    Cas Lek Cesk; 1985 Jun 07; 124(23):711-4. PubMed ID: 3874692
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N, Taneda Y, Shibata M, Mizoguchi F, Katayama M.
    Jpn J Antibiot; 1985 Feb 07; 38(2):342-58. PubMed ID: 3847522
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y, Kurosu Y, Sugita M, Nakamura H, Takahashi T, Hori M.
    Jpn J Antibiot; 1985 Feb 07; 38(2):373-413. PubMed ID: 3847524
    [Abstract] [Full Text] [Related]

  • 33. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the field of otorhinolaryngology].
    Kawamura S, Sugita R, Fujimaki Y, Deguchi K.
    Jpn J Antibiot; 1983 Mar 07; 36(3):500-8. PubMed ID: 6553606
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [The pharmacokinetics, dosage, tolerance, side effects and safety of the preparation Augmentin (a combination of amoxicillin and clavulanic acid)].
    Robinson OP.
    Antibiot Khimioter; 1992 Sep 07; 37(9):20-3. PubMed ID: 1444662
    [No Abstract] [Full Text] [Related]

  • 36. Beta-lactamase evaluation of the amoxycillin-clavulanate association.
    Novelli A, Reali EF, Fallani S, Periti P.
    Drugs Exp Clin Res; 1989 Sep 07; 15(4):151-4. PubMed ID: 2505995
    [Abstract] [Full Text] [Related]

  • 37. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
    Boon RJ, Beale AS, Comber KR, Pierce CV, Sutherland R.
    Antimicrob Agents Chemother; 1982 Sep 07; 22(3):369-75. PubMed ID: 7137980
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I, Horiguchi S, Hatae T.
    Jpn J Antibiot; 1985 Feb 07; 38(2):287-95. PubMed ID: 3847518
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.